Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
'I use any pronouns, and I'm questioning everything else': transgender youth and the issue of gender pronouns

gender (e.g., male, women, girls, transgender)

McGlashan H, Fitzpatrick K.
GSID: 4NyOQFqcZ2cJ
H McGlashan, K Fitzpatrick - Sex Education, 2018 - Taylor & Francis

… For example, Troy – a cisgendered, heterosexual man in … male to female transgender women. In an interview with two other Pasifika transgender women in the Rainbow group, the girls (…

Cite
McGlashan, H., & Fitzpatrick, K. (2018). ‘I use any pronouns, and I’m questioning everything else’: transgender youth and the issue of gender pronouns. Sex Education, 18(3), 239-252.
McGlashan, Hayley, and Katie Fitzpatrick. "‘I use any pronouns, and I’m questioning everything else’: transgender youth and the issue of gender pronouns." Sex Education 18.3 (2018): 239-252.
Copy Download .nbib Format: MLA
Prevention of schizophrenia: can it be achieved?.

CNS drugs

Lee C, McGlashan TH, Woods SW.
PMID: 15740175
CNS Drugs. 2005;19(3):193-206. doi: 10.2165/00023210-200519030-00002.

Schizophrenia is a serious mental disorder with a profound impact on patients, their caregivers and society. It is also an expensive disorder to treat, despite being relatively rare. In this paper, prevention of schizophrenia is described in terms of...

Cite
Lee C, McGlashan TH, Woods SW. Prevention of schizophrenia: can it be achieved?. CNS Drugs. 2005;19(3):193-206doi: 10.2165/00023210-200519030-00002.
Lee, C., McGlashan, T. H., & Woods, S. W. (2005). Prevention of schizophrenia: can it be achieved?. CNS drugs, 19(3), 193-206. https://doi.org/10.2165/00023210-200519030-00002
Lee, Cheng, et al. "Prevention of schizophrenia: can it be achieved?." CNS drugs vol. 19,3 (2005): 193-206. doi: https://doi.org/10.2165/00023210-200519030-00002
Lee C, McGlashan TH, Woods SW. Prevention of schizophrenia: can it be achieved?. CNS Drugs. 2005;19(3):193-206. doi: 10.2165/00023210-200519030-00002. PMID: 15740175.
Copy Download .nbib Format: NLM
A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients.

Journal of cognitive neuroscience

Hoffman RE, Rapaport J, Ameli R, McGlashan TH, Harcherik D, Servan-Schreiber D.
PMID: 23961906
J Cogn Neurosci. 1995;7(4):479-96. doi: 10.1162/jocn.1995.7.4.479.

The mechanism of hallucinated speech, a symptom commonly reported by schizophrenic patients, is unknown. The hypothesis that these hallucinations arise from pathologically altered working memory underlying speech perception was explored. A neural network computer simulation of contextually guided sequential...

Cite
Hoffman RE, Rapaport J, Ameli R, et al. A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients. J Cogn Neurosci. 1995;7(4):479-96doi: 10.1162/jocn.1995.7.4.479.
Hoffman, R. E., Rapaport, J., Ameli, R., McGlashan, T. H., Harcherik, D., & Servan-Schreiber, D. (1995). A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients. Journal of cognitive neuroscience, 7(4), 479-96. https://doi.org/10.1162/jocn.1995.7.4.479
Hoffman, R E, et al. "A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients." Journal of cognitive neuroscience vol. 7,4 (1995): 479-96. doi: https://doi.org/10.1162/jocn.1995.7.4.479
Hoffman RE, Rapaport J, Ameli R, McGlashan TH, Harcherik D, Servan-Schreiber D. A neural network simulation of hallucinated "voices" and associated speech perception impairments in schizophrenic patients. J Cogn Neurosci. 1995;7(4):479-96. doi: 10.1162/jocn.1995.7.4.479. PMID: 23961906.
Copy Download .nbib Format: NLM
DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV.

Psychosis

Woods SW, Carlson JP, McGlashan TH.
PMID: 21566681
Psychosis. 2010 Oct;2(3):187-190. doi: 10.1080/17522439.2010.511719.

The American Psychiatric Association is considering the inclusion of the psychosis risk syndrome as a new diagnosis for DSM-5. The main evidence supporting inclusion is: (1) the patients meet criteria for having a current illness, (2) the patients are...

Cite
Woods SW, Carlson JP, McGlashan TH. DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV. Psychosis. 2010;2(3):187-190doi: 10.1080/17522439.2010.511719.
Woods, S. W., Carlson, J. P., & McGlashan, T. H. (2010). DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV. Psychosis, 2(3), 187-190. https://doi.org/10.1080/17522439.2010.511719
Woods, Scott W, et al. "DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV." Psychosis vol. 2,3 (2010): 187-190. doi: https://doi.org/10.1080/17522439.2010.511719
Woods SW, Carlson JP, McGlashan TH. DSM-5 and the 'Psychosis Risk Syndrome': The DSM-5 proposal is better than DSM-IV. Psychosis. 2010 Oct;2(3):187-190. doi: 10.1080/17522439.2010.511719. PMID: 21566681; PMCID: PMC3091012.
Copy Download .nbib Format: NLM
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.

Molecular psychiatry

Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Anticevic A, Schleifer C, Adkinson BD, Ji JL, Tamayo Z, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, McGlashan TH, Perkins DO, Cadenhead KS, Tsuang MT, Woods SW, Stone WS, Shenton ME, Cannon TD, Pasternak O.
PMID: 34024906
Mol Psychiatry. 2021 Nov;26(11):6833-6844. doi: 10.1038/s41380-021-01128-8. Epub 2021 May 24.

Subtle alterations in white matter microstructure are observed in youth at clinical high risk (CHR) for psychosis. However, the timing of these changes and their relationships to the emergence of psychosis remain unclear. Here, we track the evolution of...

Cite
Di Biase MA, Cetin-Karayumak S, Lyall AE, et al. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021;26(11):6833-6844doi: 10.1038/s41380-021-01128-8.
Di Biase, M. A., Cetin-Karayumak, S., Lyall, A. E., Zalesky, A., Cho, K. I. K., Zhang, F., Kubicki, M., Rathi, Y., Lyons, M. G., Bouix, S., Billah, T., Anticevic, A., Schleifer, C., Adkinson, B. D., Ji, J. L., Tamayo, Z., Addington, J., Bearden, C. E., Cornblatt, B. A., Keshavan, M. S., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Cadenhead, K. S., Tsuang, M. T., Woods, S. W., Stone, W. S., Shenton, M. E., Cannon, T. D., & Pasternak, O. (2021). White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Molecular psychiatry, 26(11), 6833-6844. https://doi.org/10.1038/s41380-021-01128-8
Di Biase, Maria A, et al. "White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis." Molecular psychiatry vol. 26,11 (2021): 6833-6844. doi: https://doi.org/10.1038/s41380-021-01128-8
Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Anticevic A, Schleifer C, Adkinson BD, Ji JL, Tamayo Z, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, McGlashan TH, Perkins DO, Cadenhead KS, Tsuang MT, Woods SW, Stone WS, Shenton ME, Cannon TD, Pasternak O. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021 Nov;26(11):6833-6844. doi: 10.1038/s41380-021-01128-8. Epub 2021 May 24. PMID: 34024906; PMCID: PMC8611104.
Copy Download .nbib Format: NLM
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.

Molecular psychiatry

Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Anticevic A, Schleifer C, Adkinson BD, Ji JL, Tamayo Z, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, McGlashan TH, Perkins DO, Cadenhead KS, Tsuang MT, Woods SW, Stone WS, Shenton ME, Cannon TD, Pasternak O.
PMID: 34024906
Mol Psychiatry. 2021 Nov;26(11):6833-6844. doi: 10.1038/s41380-021-01128-8. Epub 2021 May 24.

Subtle alterations in white matter microstructure are observed in youth at clinical high risk (CHR) for psychosis. However, the timing of these changes and their relationships to the emergence of psychosis remain unclear. Here, we track the evolution of...

Cite
Di Biase MA, Cetin-Karayumak S, Lyall AE, et al. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021;26(11):6833-6844doi: 10.1038/s41380-021-01128-8.
Di Biase, M. A., Cetin-Karayumak, S., Lyall, A. E., Zalesky, A., Cho, K. I. K., Zhang, F., Kubicki, M., Rathi, Y., Lyons, M. G., Bouix, S., Billah, T., Anticevic, A., Schleifer, C., Adkinson, B. D., Ji, J. L., Tamayo, Z., Addington, J., Bearden, C. E., Cornblatt, B. A., Keshavan, M. S., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Cadenhead, K. S., Tsuang, M. T., Woods, S. W., Stone, W. S., Shenton, M. E., Cannon, T. D., & Pasternak, O. (2021). White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Molecular psychiatry, 26(11), 6833-6844. https://doi.org/10.1038/s41380-021-01128-8
Di Biase, Maria A, et al. "White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis." Molecular psychiatry vol. 26,11 (2021): 6833-6844. doi: https://doi.org/10.1038/s41380-021-01128-8
Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Anticevic A, Schleifer C, Adkinson BD, Ji JL, Tamayo Z, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, McGlashan TH, Perkins DO, Cadenhead KS, Tsuang MT, Woods SW, Stone WS, Shenton ME, Cannon TD, Pasternak O. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021 Nov;26(11):6833-6844. doi: 10.1038/s41380-021-01128-8. Epub 2021 May 24. PMID: 34024906; PMCID: PMC8611104.
Copy Download .nbib Format: NLM
Revision indications for medial unicompartmental knee arthroplasty: a systematic review.

Archives of orthopaedic and trauma surgery

Tay ML, McGlashan SR, Monk AP, Young SW.
PMID: 33630155
Arch Orthop Trauma Surg. 2021 Feb 25; doi: 10.1007/s00402-021-03827-x. Epub 2021 Feb 25.

INTRODUCTION: Unicompartmental knee arthroplasty (UKA) has advantages over total knee arthroplasty including fewer complications and faster recovery; however, UKAs also have higher revision rates. Understanding reasons for UKA failure may, therefore, allow for optimized clinical outcomes. We aimed to...

Cite
Tay ML, McGlashan SR, Monk AP, et al. Revision indications for medial unicompartmental knee arthroplasty: a systematic review. Arch Orthop Trauma Surg. 2021;doi: 10.1007/s00402-021-03827-x.
Tay, M. L., McGlashan, S. R., Monk, A. P., & Young, S. W. (2021). Revision indications for medial unicompartmental knee arthroplasty: a systematic review. Archives of orthopaedic and trauma surgery, . https://doi.org/10.1007/s00402-021-03827-x
Tay, Mei Lin, et al. "Revision indications for medial unicompartmental knee arthroplasty: a systematic review." Archives of orthopaedic and trauma surgery vol. (2021). doi: https://doi.org/10.1007/s00402-021-03827-x
Tay ML, McGlashan SR, Monk AP, Young SW. Revision indications for medial unicompartmental knee arthroplasty: a systematic review. Arch Orthop Trauma Surg. 2021 Feb 25; doi: 10.1007/s00402-021-03827-x. Epub 2021 Feb 25. PMID: 33630155.
Copy Download .nbib Format: NLM
Correction: Ceiling effects in the Movement Assessment Battery for Children-2 (MABC-2) suggest that non-parametric scoring methods are required.

PloS one

French B, Sycamore NJ, McGlashan HL, Blanchard CCV, Holmes NP.
PMID: 33471795
PLoS One. 2021 Jan 20;16(1):e0245674. doi: 10.1371/journal.pone.0202689. eCollection 2021.

[This corrects the article DOI: 10.1371/journal.pone.0198426.].

Cite
French B, Sycamore NJ, McGlashan HL, et al. Correction: Ceiling effects in the Movement Assessment Battery for Children-2 (MABC-2) suggest that non-parametric scoring methods are required. PLoS One. 2021;16(1):e0245674doi: 10.1371/journal.pone.0202689.
French, B., Sycamore, N. J., McGlashan, H. L., Blanchard, C. C. V., & Holmes, N. P. (2021). Correction: Ceiling effects in the Movement Assessment Battery for Children-2 (MABC-2) suggest that non-parametric scoring methods are required. PloS one, 16(1), e0245674. https://doi.org/10.1371/journal.pone.0202689
French, Blandine, et al. "Correction: Ceiling effects in the Movement Assessment Battery for Children-2 (MABC-2) suggest that non-parametric scoring methods are required." PloS one vol. 16,1 (2021): e0245674. doi: https://doi.org/10.1371/journal.pone.0202689
French B, Sycamore NJ, McGlashan HL, Blanchard CCV, Holmes NP. Correction: Ceiling effects in the Movement Assessment Battery for Children-2 (MABC-2) suggest that non-parametric scoring methods are required. PLoS One. 2021 Jan 20;16(1):e0245674. doi: 10.1371/journal.pone.0202689. eCollection 2021. PMID: 33471795; PMCID: PMC7832596.
Copy Download .nbib Format: NLM
Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up.

JAMA psychiatry

Yen S, Peters JR, Nishar S, Grilo CM, Sanislow CA, Shea MT, Zanarini MC, McGlashan TH, Morey LC, Skodol AE.
PMID: 33206138
JAMA Psychiatry. 2021 Feb 01;78(2):187-194. doi: 10.1001/jamapsychiatry.2020.3598.

IMPORTANCE: Borderline personality disorder (BPD) has been identified as a strong risk factor for suicidal behavior, including suicide attempts. Delineating specific features that increase risk could inform interventions.OBJECTIVE: To examine factors associated with prospectively observed suicide attempts among participants...

Cite
Yen S, Peters JR, Nishar S, et al. Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up. JAMA Psychiatry. 2021;78(2):187-194doi: 10.1001/jamapsychiatry.2020.3598.
Yen, S., Peters, J. R., Nishar, S., Grilo, C. M., Sanislow, C. A., Shea, M. T., Zanarini, M. C., McGlashan, T. H., Morey, L. C., & Skodol, A. E. (2021). Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up. JAMA psychiatry, 78(2), 187-194. https://doi.org/10.1001/jamapsychiatry.2020.3598
Yen, Shirley, et al. "Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up." JAMA psychiatry vol. 78,2 (2021): 187-194. doi: https://doi.org/10.1001/jamapsychiatry.2020.3598
Yen S, Peters JR, Nishar S, Grilo CM, Sanislow CA, Shea MT, Zanarini MC, McGlashan TH, Morey LC, Skodol AE. Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up. JAMA Psychiatry. 2021 Feb 01;78(2):187-194. doi: 10.1001/jamapsychiatry.2020.3598. PMID: 33206138; PMCID: PMC7675214.
Copy Download .nbib Format: NLM
North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description.

Schizophrenia research

Addington J, Liu L, Brummitt K, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD.
PMID: 32317224
Schizophr Res. 2020 Apr 18; doi: 10.1016/j.schres.2020.04.010. Epub 2020 Apr 18.

The North American Prodrome Longitudinal Study (NAPLS) is a consortium of nine programs focusing on youth at clinical high risk (CHR) for psychosis. Funded by the National Institute of Mental Health (NIMH), the sites are located at Emory University,...

Cite
Addington J, Liu L, Brummitt K, et al. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophr Res. 2020;doi: 10.1016/j.schres.2020.04.010.
Addington, J., Liu, L., Brummitt, K., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Keshavan, M., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Stone, W., Tsuang, M. T., Walker, E. F., Woods, S. W., & Cannon, T. D. (2020). North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophrenia research, . https://doi.org/10.1016/j.schres.2020.04.010
Addington, Jean, et al. "North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description." Schizophrenia research vol. (2020). doi: https://doi.org/10.1016/j.schres.2020.04.010
Addington J, Liu L, Brummitt K, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophr Res. 2020 Apr 18; doi: 10.1016/j.schres.2020.04.010. Epub 2020 Apr 18. PMID: 32317224; PMCID: PMC7572535.
Copy Download .nbib Format: NLM
Wearable light spectral sensor optimized for measuring daily α-opic light exposure.

Optics express

Mohamed A, Kalavally V, Cain SW, Phillips AJK, McGlashan EM, Tan CP.
PMID: 34615174
Opt Express. 2021 Aug 16;29(17):27612-27627. doi: 10.1364/OE.431373.

Light has many non-visual effects on human physiology, including alterations in sleep, mood, and alertness. These effects are mainly mediated by photoreceptors containing the photopigment melanopsin, which has a peak sensitivity to short wavelength ('blue') light. Commercially available light...

Cite
Mohamed A, Kalavally V, Cain SW, et al. Wearable light spectral sensor optimized for measuring daily α-opic light exposure. Opt Express. 2021;29(17):27612-27627doi: 10.1364/OE.431373.
Mohamed, A., Kalavally, V., Cain, S. W., Phillips, A. J. K., McGlashan, E. M., & Tan, C. P. (2021). Wearable light spectral sensor optimized for measuring daily α-opic light exposure. Optics express, 29(17), 27612-27627. https://doi.org/10.1364/OE.431373
Mohamed, Anas, et al. "Wearable light spectral sensor optimized for measuring daily α-opic light exposure." Optics express vol. 29,17 (2021): 27612-27627. doi: https://doi.org/10.1364/OE.431373
Mohamed A, Kalavally V, Cain SW, Phillips AJK, McGlashan EM, Tan CP. Wearable light spectral sensor optimized for measuring daily α-opic light exposure. Opt Express. 2021 Aug 16;29(17):27612-27627. doi: 10.1364/OE.431373. PMID: 34615174.
Copy Download .nbib Format: NLM
The Chondrogenic Potential of First-Trimester and Term Placental Mesenchymal Stem/Stromal Cells.

Cartilage

James JL, Umapathy A, Srinivasan S, Barker CN, Brooks A, Hearn J, Chhana A, Williams E, Sheppard H, McGlashan SR.
PMID: 34521248
Cartilage. 2021 Dec;13(2):544S-558S. doi: 10.1177/19476035211044822. Epub 2021 Sep 14.

OBJECTIVES: Mesenchymal stem/stromal cells (MSCs) are a well-established cell source for cartilage engineering, but challenges remain as differentiation often results in chondrocyte hypertrophy. Chondrogenic potential also varies with MSC source and donor age. We assessed the chondrogenic potential of...

Cite
James JL, Umapathy A, Srinivasan S, et al. The Chondrogenic Potential of First-Trimester and Term Placental Mesenchymal Stem/Stromal Cells. Cartilage. 2021;13(2):544S-558Sdoi: 10.1177/19476035211044822.
James, J. L., Umapathy, A., Srinivasan, S., Barker, C. N., Brooks, A., Hearn, J., Chhana, A., Williams, E., Sheppard, H., & McGlashan, S. R. (2021). The Chondrogenic Potential of First-Trimester and Term Placental Mesenchymal Stem/Stromal Cells. Cartilage, 13(2), 544S-558S. https://doi.org/10.1177/19476035211044822
James, Joanna L, et al. "The Chondrogenic Potential of First-Trimester and Term Placental Mesenchymal Stem/Stromal Cells." Cartilage vol. 13,2 (2021): 544S-558S. doi: https://doi.org/10.1177/19476035211044822
James JL, Umapathy A, Srinivasan S, Barker CN, Brooks A, Hearn J, Chhana A, Williams E, Sheppard H, McGlashan SR. The Chondrogenic Potential of First-Trimester and Term Placental Mesenchymal Stem/Stromal Cells. Cartilage. 2021 Dec;13(2):544S-558S. doi: 10.1177/19476035211044822. Epub 2021 Sep 14. PMID: 34521248.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries